$ZWS

Zurn Elkay Water Solutions earnings beat by $0.02, revenue topped estimates

Zurn Elkay Water Solutions (ZWS) reported Q2 EPS of $0.52, beating estimates by $0.02, with revenue of $495M, slightly above expectations. The company provided Q4 2026 revenue guidance of $430M-$437M, below the consensus of $438.10M. ZWS stock is down 2.69% over the last 3 months but up 6.84% year-over-year. The company's Financial Health score is rated as 'great performance' according to InvestingPro.

Original reporting
Published Oct 27, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ZWS
Neutral
high confidence
Mentioned
$ZWS
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ZWSNeutralHigh
01

Why it matters

Earnings beat provides short‑term upside, but below‑consensus guidance may trigger profit‑taking.

02

Market read

Fresh earnings and guidance data give traders a clear decision point on ZWS.

03

What to watch

Potential cost pressures or market saturation not discussed in the release.

Relevance 8/10Novelty 8/10Timing: after market close

Background

Zurn Elkay Water Solutions (NYSE: ZWS) provides water infrastructure products and services.

Company-level read

Ticker impact

$ZWSNeutralHigh confidence
Context

Zurn Elkay Water Solutions reported Q2 EPS of $0.52 beating estimates and gave Q4 revenue guidance below consensus.

Expected impact

likely downside pressure as Q4 revenue guidance falls short of analyst expectations

Evidence & confidence

The beat is modest ($0.02) and guidance is below consensus, suggesting mixed market reaction.

Market effects

Water solutions sector may see slight re‑rating as peers compare guidance.

Limited to US mid‑cap investors.

Low

Counterpoint

The beat could be overstated; focus on guidance miss may drive a sell‑off.

Key entities

  • Zurn Elkay Water Solutions

    Provider of water infrastructure solutions, ticker ZWS.

Related articles

$ZWSHigh

Zurn Elkay Water Solutions Reports Third Quarter 2026 Financial Results

Zurn Elkay Water Solutions Corp (ZWS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release October 27, 2026 Contact Information: For Immediate Release Bobbi Belstner Vice President, Corporate Controller 414.361.0122 Zurn Elkay Water Solutions Reports Third Quarter 2026 Financial Results Investor call scheduled for Wednesday, October 28, 2026

$ZWSMed

Stifel cuts Zurn Water Solutions stock price target on construction outlook

Stifel reduced its price target for Zurn Water Solutions (ZWS) to $56 from $62, keeping a Buy rating. The stock is currently at $47.06, with 9 analysts revising earnings upwards. ZWS reported Q2 2026 earnings of $0.50 per share, beating estimates, and revenue of $491 million, also above forecasts. The company has a strong financial health and expects stable demand and improved pricing in 2H 2026.

$AAONMed

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

$ZWSMed

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

$ZWSMed

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.